Overview

A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
This study was an randomized, double-Blind, placebo-controlled, multicenter Phase II/III study.
Phase:
PHASE3
Details
Lead Sponsor:
Shandong New Time Pharmaceutical Co., LTD
Treatments:
Valsartan